Key result
Demographic ageing explains ~94% of later Parkinson's onset, while diabetes, hypertension, and pollution influence timing.
Why the study?
This study aimed to examine temporal trends in Parkinson's disease age at onset over the past four decades and identify independent associations with demographic, cardiovascular/dysmetabolic, lifestyle, and environmental variables.
What are the demographic and modifiable determinants of age at onset in Parkinson's disease?
Observational (n=13,220)
No
What are the demographic and modifiable determinants of age at onset in Parkinson's disease?
Cardiovascular comorbidities such as type 2 diabetes and hypertension are associated with a later age at onset of Parkinson's disease, while environmental toxins and family history are associated with earlier onset.
BACKGROUND: Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder, with age at onset (AAO) influenced by genetic and environmental factors. This study aimed to (i) examine temporal trends in PD AAO over the past four decades in a large tertiary care cohort; and (ii) identify independent associations between AAO and a comprehensive set of demographics, cardiovascular/dysmetabolic, lifestyle, and environmental variables. METHODS: We conducted a retrospective observational study of 13,220 individuals diagnosed with PD between 1998 and 2024 at a tertiary referral center in Italy, excluding genetically confirmed cases. Demographic, clinical, and exposure data were collected via questionnaires and interviews. Temporal trends in AAO were analysed in relation to national population ageing. Independent predictors of AAO were identified using multivariable linear regression with cross-validation and multiple imputation. Age- and sex-stratified analyses were also performed. RESULTS: = 0.94), without evidence of additional temporal acceleration (P = 0.852). An earlier AAO was independently associated with a positive family history of PD (β = -2.96, P < 0.0001), pollutant exposure (β = -3.50, P < 0.0001), and higher education level (β = -0.52, P < 0.0001). In contrast, type 2 diabetes mellitus (β = + 2.63, P < 0.0001) and hypertension (β = + 2.24, P < 0.0001) were associated with later onset. Among women, later menarche was linked to delayed AAO (β = + 0.60, P < 0.0001). CONCLUSIONS: While demographic ageing largely accounts for the temporal increase in AAO, modifiable exposures, particularly cardiovascular/dysmetabolic comorbidities and environmental toxins, can significantly influence disease timing, though causal interpretation is limited by accumulation bias.
No takes yet. Share an insight, caveat, or question.
Contaldi et al. (2026) conducted an observational in Parkinson's disease (n=13,220). Demographic, cardiovascular/dysmetabolic, lifestyle, and environmental factors was evaluated on Age at onset (AAO) of Parkinson's disease (R2 = 0.94). Demographic ageing largely accounted for the temporal increase in Parkinson's disease age at onset (R2 = 0.94), while type 2 diabetes, hypertension, and pollutant exposure significantly influenced disease timing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: